Todd  Berard net worth and biography

Todd Berard Biography and Net Worth

Todd Berard was named Chief Marketing Officer at BioLife in December 2019. Todd joined BioLife as Senior Director of Marketing in 2014 and was promoted to Vice President the following year.

Before joining BioLife, Todd was Director of Marketing at Verathon Medical, a division of Roper Inc., from September 2010 until July 2014. In this capacity, Todd oversaw the creative and product management teams and was responsible for the global marketing, product development, and product launch strategies for a portfolio of six medical device brands. He also managed all strategic partnerships for product development and helped guide Verathon Medical through several key product launches and a corporate acquisition. His responsibilities included all global marketing initiatives and campaigns, strategy, product portfolio management, and strategic planning. Todd has over 20 years of experience in the life sciences, including health care, medical devices, and technology. He has worked for a wide range of entities, ranging from the University of Washington School of Medicine to DuPont, and Medtronic.

Todd has a Bachelor of Science Degree in Biochemistry from the University of Vermont and an MBA from the University of Washington Foster School of Business.

What is Todd Berard's net worth?

The estimated net worth of Todd Berard is at least $2.83 million as of November 26th, 2024. Mr. Berard owns 107,407 shares of BioLife Solutions stock worth more than $2,826,952 as of December 11th. This net worth estimate does not reflect any other assets that Mr. Berard may own. Additionally, Mr. Berard receives a salary of $286,490.00 as CMO at BioLife Solutions. Learn More about Todd Berard's net worth.

How old is Todd Berard?

Mr. Berard is currently 55 years old. There are 6 older executives and no younger executives at BioLife Solutions. The oldest executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who is 64 years old. Learn More on Todd Berard's age.

What is Todd Berard's salary?

As the CMO of BioLife Solutions, Inc., Mr. Berard earns $286,490.00 per year. There are 4 executives that earn more than Mr. Berard. The highest earning executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who commands a salary of $1,630,000.00 per year. Learn More on Todd Berard's salary.

How do I contact Todd Berard?

The corporate mailing address for Mr. Berard and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Todd Berard's contact information.

Has Todd Berard been buying or selling shares of BioLife Solutions?

During the last quarter, Todd Berard has sold $19,089.39 of BioLife Solutions stock. Most recently, Todd Berard sold 349 shares of the business's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $27.20, for a transaction totalling $9,492.80. Following the completion of the sale, the chief marketing officer now directly owns 107,407 shares of the company's stock, valued at $2,921,470.40. Learn More on Todd Berard's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 74 times. They sold a total of 135,966 shares worth more than $2,718,539.10. The most recent insider tranaction occured on November, 26th when CFO Troy Wichterman sold 581 shares worth more than $15,803.20. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 11/26/2024.

Todd Berard Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/26/2024Sell349$27.20$9,492.80107,407View SEC Filing Icon  
11/12/2024Sell91$26.34$2,396.94107,756View SEC Filing Icon  
10/30/2024Sell311$23.15$7,199.65107,847View SEC Filing Icon  
9/16/2024Sell367$25.12$9,219.04108,158View SEC Filing Icon  
8/21/2024Sell82$25.61$2,100.02108,525View SEC Filing Icon  
7/11/2024Sell287$20.54$5,894.98108,607View SEC Filing Icon  
6/14/2024Sell10,000$20.18$201,800.00108,894View SEC Filing Icon  
5/29/2024Sell345$21.78$7,514.10118,894View SEC Filing Icon  
5/17/2024Sell73$22.18$1,619.14119,239View SEC Filing Icon  
4/18/2024Sell332$15.31$5,082.92129,312View SEC Filing Icon  
4/15/2024Sell10,000$15.67$156,700.00129,644View SEC Filing Icon  
3/27/2024Sell515$17.99$9,264.85139,644View SEC Filing Icon  
3/11/2024Sell401$17.42$6,985.42147,266View SEC Filing Icon  
2/21/2024Sell111$17.35$1,925.85115,688View SEC Filing Icon  
1/19/2024Sell1,232$16.76$20,648.32115,799View SEC Filing Icon  
1/2/2024Sell491$16.75$8,224.25117,031View SEC Filing Icon  
12/1/2023Sell394$12.37$4,873.78117,522View SEC Filing Icon  
11/13/2023Sell98$10.77$1,055.46117,916View SEC Filing Icon  
9/28/2023Sell464$14.16$6,570.24118,014View SEC Filing Icon  
8/14/2023Sell134$12.38$1,658.92118,825View SEC Filing Icon  
6/27/2023Sell489$22.91$11,202.99118,959View SEC Filing Icon  
5/31/2023Sell337$23.21$7,821.77119,448View SEC Filing Icon  
5/15/2023Sell92$18.71$1,721.32119,785View SEC Filing Icon  
4/6/2023Sell1,545$20.03$30,946.35116,267View SEC Filing Icon  
3/29/2023Sell521$20.62$10,743.02117,812View SEC Filing Icon  
3/1/2023Sell874$22.75$19,883.50118,333View SEC Filing Icon  
2/8/2023Sell9,000$25.13$226,170.00119,265View SEC Filing Icon  
1/23/2023Sell3,500$25.01$87,535.00119,265View SEC Filing Icon  
1/18/2023Sell6,500$25.04$162,760.00119,265View SEC Filing Icon  
12/28/2022Sell501$16.90$8,466.90107,380View SEC Filing Icon  
11/10/2022Sell50$23.16$1,158.00107,881View SEC Filing Icon  
9/29/2022Sell463$23.02$10,658.26107,931View SEC Filing Icon  
8/10/2022Sell52$23.17$1,204.84108,394View SEC Filing Icon  
6/28/2022Sell495$14.86$7,355.70108,446View SEC Filing Icon  
5/13/2022Sell51$12.32$628.32108,941View SEC Filing Icon  
4/18/2022Sell13,581$17.59$238,889.79108,992View SEC Filing Icon  
3/29/2022Sell475$22.24$10,564.00View SEC Filing Icon  
2/10/2022Sell254$29.38$7,462.52View SEC Filing Icon  
12/29/2021Sell517$39.37$20,354.29View SEC Filing Icon  
11/15/2021Sell6,160$47.96$295,433.60View SEC Filing Icon  
10/15/2021Sell6,160$40.76$251,081.60View SEC Filing Icon  
9/28/2021Sell505$43.12$21,775.60View SEC Filing Icon  
9/15/2021Sell6,160$49.01$301,901.60View SEC Filing Icon  
8/17/2021Sell6,160$44.80$275,968.0085,224View SEC Filing Icon  
7/15/2021Sell6,165$42.74$263,492.10View SEC Filing Icon  
6/15/2021Sell6,160$39.38$242,580.8085,726View SEC Filing Icon  
5/14/2021Sell6,160$29.68$182,828.8085,726View SEC Filing Icon  
4/16/2021Sell6,160$33.38$205,620.8085,726View SEC Filing Icon  
4/1/2021Sell2,825$36.53$103,197.2580,029View SEC Filing Icon  
3/26/2021Sell2,120$35.01$74,221.2072,750View SEC Filing Icon  
3/16/2021Sell6,160$36.72$226,195.2081,030View SEC Filing Icon  
2/18/2021Sell1,882$40.67$76,540.9467,488View SEC Filing Icon  
2/16/2021Sell12,324$44.48$548,171.5270,042View SEC Filing Icon  
11/13/2020Sell5,000$32.16$160,800.0069,878View SEC Filing Icon  
9/29/2020Sell808$28.63$23,133.0463,878View SEC Filing Icon  
12/16/2019Sell3,000$15.68$47,040.0044,074View SEC Filing Icon  
11/14/2019Sell3,000$14.06$42,180.0044,074View SEC Filing Icon  
9/16/2019Sell3,000$20.02$60,060.0044,074View SEC Filing Icon  
8/15/2019Sell3,000$17.97$53,910.0044,074View SEC Filing Icon  
7/15/2019Sell3,000$16.58$49,740.0044,074View SEC Filing Icon  
6/17/2019Sell3,000$17.47$52,410.0044,074View SEC Filing Icon  
5/15/2019Sell3,000$16.96$50,880.0044,074View SEC Filing Icon  
4/15/2019Sell3,000$17.56$52,680.0044,074View SEC Filing Icon  
3/14/2019Sell3,000$16.67$50,010.0044,074View SEC Filing Icon  
2/14/2019Sell3,000$16.07$48,210.0037,583View SEC Filing Icon  
1/15/2019Sell3,000$12.12$36,360.0037,583View SEC Filing Icon  
9/21/2018Sell3,000$17.23$51,690.0037,583View SEC Filing Icon  
See Full Table

Todd Berard Buying and Selling Activity at BioLife Solutions

This chart shows Todd Berard's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $26.32
Low: $26.14
High: $26.92

50 Day Range

MA: $24.49
Low: $20.47
High: $27.47

2 Week Range

Now: $26.32
Low: $12.45
High: $28.88

Volume

151,049 shs

Average Volume

384,304 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91